ARQT vs. AGIO
Compare and contrast key facts about Arcutis Biotherapeutics, Inc. (ARQT) and Agios Pharmaceuticals, Inc. (AGIO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: ARQT or AGIO.
Correlation
The correlation between ARQT and AGIO is 0.36, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Performance
ARQT vs. AGIO - Performance Comparison
Key characteristics
ARQT:
1.25
AGIO:
0.80
ARQT:
2.10
AGIO:
1.55
ARQT:
1.24
AGIO:
1.20
ARQT:
1.15
AGIO:
0.58
ARQT:
4.52
AGIO:
2.56
ARQT:
21.51%
AGIO:
18.82%
ARQT:
77.19%
AGIO:
60.63%
ARQT:
-95.02%
AGIO:
-87.36%
ARQT:
-64.58%
AGIO:
-74.81%
Fundamentals
ARQT:
$1.53B
AGIO:
$1.94B
ARQT:
-$1.67
AGIO:
$11.80
ARQT:
$125.18M
AGIO:
$25.77M
ARQT:
$112.96M
AGIO:
$19.92M
ARQT:
-$109.21M
AGIO:
-$297.76M
Returns By Period
In the year-to-date period, ARQT achieves a -5.96% return, which is significantly lower than AGIO's 3.50% return.
ARQT
-5.96%
-10.40%
45.56%
117.61%
-11.99%
N/A
AGIO
3.50%
5.65%
-20.18%
43.32%
-6.83%
-10.90%
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Risk-Adjusted Performance
ARQT vs. AGIO — Risk-Adjusted Performance Rank
ARQT
AGIO
ARQT vs. AGIO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for Arcutis Biotherapeutics, Inc. (ARQT) and Agios Pharmaceuticals, Inc. (AGIO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
ARQT vs. AGIO - Dividend Comparison
Neither ARQT nor AGIO has paid dividends to shareholders.
Drawdowns
ARQT vs. AGIO - Drawdown Comparison
The maximum ARQT drawdown since its inception was -95.02%, which is greater than AGIO's maximum drawdown of -87.36%. Use the drawdown chart below to compare losses from any high point for ARQT and AGIO. For additional features, visit the drawdowns tool.
Volatility
ARQT vs. AGIO - Volatility Comparison
Arcutis Biotherapeutics, Inc. (ARQT) has a higher volatility of 18.93% compared to Agios Pharmaceuticals, Inc. (AGIO) at 12.25%. This indicates that ARQT's price experiences larger fluctuations and is considered to be riskier than AGIO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
ARQT vs. AGIO - Financials Comparison
This section allows you to compare key financial metrics between Arcutis Biotherapeutics, Inc. and Agios Pharmaceuticals, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities